Rockwell Medical (RMTI) Reports Q1 Loss of $0.84/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- S&P Global explores potential separation of Capital IQ business
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Rockwell Medical Provides First Quarter 2022 Financial and Operational Update
May 16, 2022 4:02 PM EDT- First quarter net sales of $16.1 million, up 4.2% year-over-year -Â
- Submitted Supplemental Data to FDA for IND Application to enable Phase 2 FPC Home Infusion Trial -
- Amended and expanded supply agreement with DaVita, including $7.5M investment, strengthens Rockwell's financial position, laying groundwork for profitable concentrates business -
- Completion of patient enrollment ahead of schedule in pivotal Phase 3 trial of Triferic® in China -
- Conference call and webcast scheduled for today at 4:15 p.m. ET... More



